Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
26.19
+0.36 (1.39%)
At close: Aug 14, 2026, 4:00 PM EDT
25.88
-0.31 (-1.18%)
After-hours: Aug 14, 2026, 7:51 PM EDT
Arcutis Biotherapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $34 | Buy | Reiterates | $34 | +29.82% | Aug 11, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Reiterates $34 → $38 | Buy | Reiterates | $34 → $38 | +45.09% | Aug 6, 2026 |
| Needham | Needham | Buy Reiterates $40 | Buy | Reiterates | $40 | +52.73% | Aug 6, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $35 → $38 | Buy | Reiterates | $35 → $38 | +45.09% | Aug 6, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $35 | Buy | Maintains | $35 | +33.64% | Aug 6, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Reiterates $35 → $36 | Buy | Reiterates | $35 → $36 | +37.46% | Aug 6, 2026 |
Unknown Analyst Jefferies No rating | Jefferies | Buy Maintains $35 | Buy | Maintains | $35 | +33.64% | Jul 9, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $29 → $33 | Hold | Maintains | $29 → $33 | +26.00% | Feb 27, 2026 |